ABSTRACT
We aimed to evaluate the total costs to patients and their partners of sleep apnoea and obesity hypoventilation syndrome (OHS) and their treatment, as this is poorly described in families. Using data from the Danish National Patient Registry and other public databases, all patients and their partners with a diagnosis of sleep apnoea (n=30,278) or OHS (n=1562) were included. They were compared with age-, sex- and community location-matched citizens at a ratio 1:4 (120,506 and 6241 control subjects, respectively). Direct and indirect costs were evaluated for patients and their partners. Sleep apnoea and OHS patients and their partners had higher rates of health-related contact, medication use and unemployment, and lower income levels. Excess yearly direct net health and foregone earnings (indirect costs) were 2174 and 7981 prior to diagnosis, and 3988 and 12,022 after diagnosis for sleep apnoea and OHS, respectively. The comparable annual mean excess health-related costs for spouses were 1965 and 2862 before diagnosis, and 2307 and 3079 after diagnosis, for sleep apnoea and OHS patients, respectively. These socioeconomic consequences were present up to 12 years before first diagnosis, and increased as the disease advanced. Sleep-disordered breathing has major socioeconomic consequences for patients and their spouses years before and after diagnosis.
Subject(s)
Cost of Illness , Health Care Costs/statistics & numerical data , Health Services/statistics & numerical data , Income/statistics & numerical data , Obesity Hypoventilation Syndrome/economics , Sleep Apnea Syndromes/economics , Spouses/statistics & numerical data , Adult , Aged , Aged, 80 and over , Case-Control Studies , Denmark , Drug Costs/statistics & numerical data , Female , Health Services/economics , Humans , Male , Middle Aged , Unemployment/statistics & numerical data , Young AdultSubject(s)
Health Expenditures/statistics & numerical data , Sleep Apnea, Obstructive/economics , Cost-Benefit Analysis/economics , Female , Health Services/economics , Health Services/statistics & numerical data , Humans , Obesity Hypoventilation Syndrome/economics , Obesity Hypoventilation Syndrome/therapy , Quality-Adjusted Life Years , Sleep Apnea, Obstructive/therapy , United StatesABSTRACT
STUDY OBJECTIVES: To determine the effect of obesity and sleep apnea on health care expenditure in women over 10 years. DESIGN: Retrospective observational study SETTING: Tertiary university-based medical center PATIENTS AND CONTROLS: Three groups of age-matched women: 223 obese women with OSAS (body mass index: 39.3 +/- 0.6 kg/m2), and from the general population, 223 obese controls (BMI 36.3 +/- 0.4) and 223 normal weight controls (BMI 23.9 +/- 0.4). INTERVENTIONS: None. MEASUREMENTS AND RESULTS: We examined health care utilization in the 3 matched groups for the 10 years leading up to the documentation of OSAS. The mean physician fees and the number of physician visits were significantly higher in obese controls than in normal weight controls during the observed period. Physician fees and physician visits progressively increased in the 10 years before diagnosis in the OSAS cases and were significantly higher than in the matched obese controls. Physician fees, in Canadian dollars, one year before diagnosis in the OSAS cases were higher than in obese controls: $547.49 +/- 34.79 vs $246.85 +/- 20.88 (P<0.0001). More was spent for OSAS cases on physician fees for circulatory, endocrine and metabolic diseases, and mental disorders than the obese controls. Physician visits one year before diagnosis in the OSAS cases were more frequent than in the obese controls: 13.2 +/- 0.73 visits vs 7.26 +/- 0.49 visits (P<0.0001). CONCLUSIONS: Obese women are heavier users of health services than normal weight controls. Obese women with OSAS use significantly more health services than obese controls. Since OSAS imposes a greater financial burden, treatment of OSAS may reduce other comorbidities and lower overall medical costs.